유방 생검 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,352,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,055,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 유방 생검 시장에 대한 상세한 조사 보고서를 발표했습니다. 이 보고서는 시장 촉진요인, 동향, 기회, 과제 등 주요 시장 역학에 대한 상세한 분석을 통해 시장 구조에 대한 종합적인 인사이트를 제공합니다.

주요 인사이트

• 유방 생검 시장 규모(2024E) : 23억 달러
• 예상 시장 가치(2033F) : 38억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 5.7%

유방 생검 시장 - 보고서 범위:

유방 생검 시장에는 검사를 위해 작은 조직 샘플을 채취하여 유방암을 진단하기 위한 다양한 제품이 포함됩니다. 이 시장에는 암의 조기 발견 및 진단에 필수적인 바늘 생검, 개복 수술 생검, 진공 보조 생검 등 다양한 유형의 유방 생검이 포함됩니다. 이 시장은 병원, 진단센터, 외래 수술센터 등 다양한 부문에 서비스를 제공하고 있으며, 직판 및 의료용품 판매점 등 다양한 채널을 통해 유통되고 있습니다. 유방암 검진에 대한 인식 증가, 유방암 유병률 증가, 생검 기술의 기술적 진보 등이 성장의 원동력이 되고 있습니다.

시장 성장 촉진요인:

유방 생검 세계 시장을 이끄는 몇 가지 요인이 있습니다. 전 세계적으로 유방암 발병률이 증가함에 따라 유방 생검에 대한 수요가 증가하고 있습니다. 생검 장비와 시술의 기술적 발전은 이러한 시술의 정확성과 편의성을 향상시켜 시장 확대에 박차를 가하고 있습니다. 또한 유방암 조기 검진 및 진단에 대한 인식과 노력이 높아지면서 유방암 생검에 대한 수요가 증가하고 있습니다. 의료비 지출 증가와 예방적 건강 관리에 대한 관심도 시장 확대에 기여하고 있습니다.

시장 억제요인:

유방 생검 시장은 유망한 성장 전망에도 불구하고 고급 생검 장비 및 시술의 높은 비용, 불편함 및 감염 위험과 같은 잠재적 문제와 관련된 과제에 직면해 있습니다. 또한, 의료기기 안전에 대한 엄격한 규제와 진화하는 임상적 요구에 대응하기 위한 지속적인 기술 혁신의 필요성에 의해 시장도 영향을 받고 있습니다. 이러한 문제를 해결하고 경쟁력을 유지하기 위해서는 효과적인 환자 교육, 경쟁력 있는 가격 책정, 연구개발에 대한 지속적인 투자가 필요합니다.

시장 기회:

시장 개척은 정확하고 편안한 진단 솔루션에 대한 수요 증가에 대응하기 위해 고품질의 최소침습적 생검 장비를 개발하기 위해 노력하고 있습니다. 신흥 경제국의 의료 인프라 확대는 시장 성장을 위한 새로운 채널을 제공하여 기업이 더 많은 사람들에게 다가갈 수 있는 기회를 제공하고 있습니다. 도시화의 진전과 건강에 대한 관심이 높아지면서 유방 생검에 대한 수요가 증가하고 있습니다. 전략적 파트너십, 신기술에 대한 투자, 혁신적인 생검 장비의 도입은 새로운 비즈니스 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.

본 보고서에서 다루는 주요 질문들

• 세계 유방 생검 시장의 성장을 촉진하는 주요 요인은 무엇인가?
• 다양한 환경에서 어떤 종류의 유방 생검술과 용도가 채택을 주도하고 있는가?
• 기술의 발전은 유방 생검 시장의 경쟁 상황에 어떤 영향을 미쳤습니까?
• 유방 생검 시장의 주요 플레이어는 누구이며 경쟁을 유지하기 위해 어떤 전략을 취하고 있는가?
• 세계 유방 생검 시장의 새로운 트렌드와 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 배제

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 부가가치 인사이트

• 제품 채용/사용 상황 분석
• 제조업체별 주요 프로모션 전략
• 규제 시나리오
• PESTLE 분석
• Porters 분석
• 신제품 발매
• 기술 평가

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별 매출
  • 적응증별 매출
  • 최종사용자별 매출
  • 국가별 매출
• 2024년 시장 시나리오

제7장 세계 시장 수요(수량) 분석

• 시장(수량) 분석, 2019-2023년
• 시장(수량) 예측, 2024-2033년
  • 전년비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 제품별 지역별 가격 분석
• 가격 내역
  • 제조업체 레벨 가격 설정
  • 유통업체 레벨 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격 설정 가정

제9장 세계 시장 수요(금액) 분석

• 시장(금액) 분석, 2019-2023년
• 시장(금액) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제10장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액 및 수량) 분석, 2019-2023년
• 시장 규모(금액 및 수량) 석과 예측, 2024-2033년
  • 생검침
    • 코어 니들
    • 미세 흡인침
  • MRI 가이드 생검 시스템
  • 초음파 유도하 유방 생검 시스템
    • 2차원(2D) 맘모그래피 초음파 스캔 시스템
    • 3차원(3D) B모드 맘모그래피 초음파 스캔 시스템
  • 흡인 보조 기기(VAD)
  • 가이드와이어(로컬리제이션 와이어)
  • 유방 생검 마커
• 제품별 시장 매력 분석

제11장 적응증별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 석과 예측, 2024-2033년
  • 복합 낭종
  • 고형 덩어리
  • 의심스러운 고형 덩어리(섬유선종)
  • 의심스러운 미세 석회화
• 적응증별 시장 매력 분석

제12장 최종사용자별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 석과 예측, 2024-2033년
  • 병원
  • 전문 클리닉
  • 외래 수술 센터
  • 암 조사 기관
• 최종사용자별 시장 매력 분석

제13장 지역별 : 세계 시장 분석

• 소개
• 시장 규모(금액 및 수량) 분석, 2019-2023년
• 시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장 매력 분석

제14장 북미 시장 분석

제15장 라틴아메리카 시장 분석

제16장 유럽 시장 분석

제17장 남아시아 시장 분석

제18장 동아시아 시장 분석

제19장 오세아니아 시장 분석

제20장 중동 및 아프리카 시장 분석

제21장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석(%)
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 주요 기업에 의한 브랜딩과 프로모션 전략
• 주요 개발 분석
• 경쟁 상세
  • Argon Medical Devices
  • Becton Dickinson and Company
  • CR Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineer

제23장 사용되는 가정과 두문자어

제24장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently published a detailed report on the global Breast Biopsy Market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

• Breast Biopsy Market Size (2024E): USD 2.3 Bn
• Projected Market Value (2033F): USD 3.8 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 5.7%

Breast Biopsy Market - Report Scope:

The Breast Biopsy Market encompasses a variety of products designed to diagnose breast cancer by removing a small tissue sample for examination. This market includes different types of breast biopsy procedures, such as needle biopsy, open surgical biopsy, and vacuum-assisted biopsy, which are essential for early cancer detection and diagnosis. The market serves diverse segments, including hospitals, diagnostic centers, and ambulatory surgical centers, distributed through various channels like direct sales and medical supply distributors. Growth is driven by increasing awareness of breast cancer screening, rising prevalence of breast cancer, and technological advancements in biopsy techniques.

Market Growth Drivers:

Several key factors drive the global Breast Biopsy Market. The rising incidence of breast cancer globally boosts the demand for breast biopsy procedures. Technological advancements in biopsy devices and techniques enhance the accuracy and comfort of these procedures, fueling market expansion. Additionally, the growing awareness and initiatives for early breast cancer screening and diagnosis drive the demand for breast biopsy. Increased healthcare expenditure and a focus on preventive health measures also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Breast Biopsy Market faces challenges related to the high cost of advanced biopsy devices and procedures and potential issues associated with their use, such as discomfort and risk of infection. The market is also impacted by the presence of stringent regulations on medical device safety and the need for continuous innovation to meet evolving clinical needs. Effective patient education, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of early cancer detection and increasing awareness about the benefits of breast cancer screening.The development of high-quality and minimally invasive biopsy devices caters to the growing demand for accurate and comfortable diagnostic solutions. The expansion of healthcare infrastructure in emerging economies provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious individuals drive the demand for breast biopsy procedures. Strategic partnerships, investments in new technologies, and the introduction of innovative biopsy devices are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Breast Biopsy Market globally?
• Which types and applications of breast biopsy procedures are leading the adoption in various settings?
• How are technological advancements influencing the competitive landscape of the Breast Biopsy Market?
• Who are the key players in the Breast Biopsy Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Breast Biopsy Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Biopsy Market, including Hologic, Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy devices and techniques, such as vacuum-assisted and stereotactic biopsy systems. Collaborations with healthcare providers, research institutions, and medical device distributors facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Breast Biopsy Market landscape.

Key Companies Profiled:

• Argon Medical
• Becton Dickinson and Company
• C.R. Bard, Inc.
• Cook Medical Inc.
• Devicor Medical Products, Inc.
• F. Hoffmann-La Roche Ltd.,
• GE Healthcare
• Hologic, Inc.
• Leica Biosystems
• Medax Srl Unipersonale
• Planmed Oy
• Scion Medical Technologies, LLC
• Siemens Healthineers
• Hikma Pharmaceuticals
• Incytes

Breast Biopsy Market Industry Segmentation

By Product:

• Biopsy Needles
• MRI-Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy Systems
• Vacuum-Assisted Devices (VAD)
• Guide Wire (Localization Wire)
• Breast Biopsy Markers

Indication:

• Complex Cysts
• Solid Mass
• Suspicious Solid Mass (Fibroadenoma)
• Suspicious Micro-calcifications

End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply-Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusion

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Value Added Insights

• 4.1. Product Adoption / Usage Analysis
• 4.2. Key Promotional Strategies, by Manufacturers
• 4.3. Regulatory Scenario
• 4.4. PESTLE Analysis
• 4.5. Porter's Analysis
• 4.6. New Product Launches
• 4.7. Technology Assessment

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising demand for Breast Biopsy Devices
  • 5.2.2. Cost of Procedures
  • 5.2.3. Adoption Rate
  • 5.2.4. Increase in Research and Development
  • 5.2.5. Availability of Product
  • 5.2.6. Strategic Mergers and Collaborations Among Players
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. Revenue by Product
  • 6.1.2. Revenue By Indication
  • 6.1.3. Revenue By End User
  • 6.1.4. Revenue By Country
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Volume Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume (Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume (units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

• 8.1. Regional Pricing Analysis by Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) & Volume (Units) Analysis by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
  • 10.3.1. Biopsy Needle
    • 10.3.1.1. Core Needles
    • 10.3.1.2. Fine Aspiration Needles
  • 10.3.2. MRI-Guide Biopsy Systems
  • 10.3.3. Ultrasound Guided Breast Biopsy Systems
    • 10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
    • 10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 10.3.4. Vacuum-Assisted Device (VAD)
  • 10.3.5. Guide Wire (Localization Wire)
  • 10.3.6. Breast Biopsy Marker
• 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis by Indication, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
  • 11.3.1. Complex Cyst
  • 11.3.2. Solid Mass
  • 11.3.3. Suspicious Solid Mass (Fibroadenoma)
  • 11.3.4. Suspicious Micro Calcifications
• 11.4. Market Attractiveness Analysis by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Specialty Clinics
  • 12.3.3. Ambulatory Surgical Centers
  • 12.3.4. Cancer Research Institutes
• 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East & Africa(MEA)
• 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By End User
  • 14.8.2. Canada Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By End-User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Brazil Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By End User
  • 15.8.2. Mexico Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By End User
  • 15.8.3. Argentina Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Nordic Countries
    • 16.3.1.8. Russia
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By End User
  • 16.8.2. Italy Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By End User
  • 16.8.3. France Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By End User
  • 16.8.4. U.K. Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By End User
  • 16.8.5. Spain Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Indication
      • 16.8.5.2.3. By End User
  • 16.8.6. BENELUX Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Indication
      • 16.8.6.2.3. By End User
  • 16.8.7. Nordic Countries Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Indication
      • 16.8.7.2.3. By End User
  • 16.8.8. Russia Market
    • 16.8.8.1. Introduction
    • 16.8.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.8.2.1. By Product
      • 16.8.8.2.2. By Indication
      • 16.8.8.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By End User
  • 17.8.2. Thailand Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By End User
  • 17.8.3. Indonesia Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Indication
      • 17.8.3.2.3. By End User
  • 17.8.4. Malaysia Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By Indication
      • 17.8.4.2.3. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. China Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By End User
  • 18.8.2. Japan Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By End User
  • 18.8.3. South Korea Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Indication
      • 18.8.3.2.3. By End User

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Indication
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Indication
  • 19.4.4. By End User
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Indication
      • 19.8.1.2.3. By End User
  • 19.8.2. New Zealand Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Indication
      • 19.8.2.2.3. By End User

20. Middle East & Africa Market Analysis 2019-2023and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. South Africa
    • 20.3.1.4. North Africa
    • 20.3.1.5. Rest of MEA
  • 20.3.2. By Product
  • 20.3.3. By Indication
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Indication
  • 20.4.4. By End User
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Market
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Indication
      • 20.8.1.2.3. By End User
  • 20.8.2. Turkiye Market
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Indication
      • 20.8.2.2.3. By End User
  • 20.8.3. South Africa Market
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Indication
      • 20.8.3.2.3. By End User
  • 20.8.4. North Africa Market
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By Indication
      • 20.8.4.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players (%)
• 21.3. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Branding and Promotional Strategies, by Key Players
• 22.3. Key Development Analysis
• 22.4. Competition Deep Dive
  • 22.4.1. Argon Medical Devices
    • 22.4.1.1. Overview
    • 22.4.1.2. Product Portfolio
    • 22.4.1.3. Key Financial
    • 22.4.1.4. Sales Footprint
    • 22.4.1.5. SWOT Analysis
    • 22.4.1.6. Strategy Overview
      • 22.4.1.6.1. Marketing Strategies
      • 22.4.1.6.2. Product Strategies
      • 22.4.1.6.3. Channel Strategies
  • 22.4.2. Becton Dickinson and Company
    • 22.4.2.1. Overview
    • 22.4.2.2. Product Portfolio
    • 22.4.2.3. Key Financial
    • 22.4.2.4. Sales Footprint
    • 22.4.2.5. SWOT Analysis
    • 22.4.2.6. Strategy Overview
      • 22.4.2.6.1. Marketing Strategies
      • 22.4.2.6.2. Product Strategies
      • 22.4.2.6.3. Channel Strategies
  • 22.4.3. C. R. Bard, Inc.
    • 22.4.3.1. Overview
    • 22.4.3.2. Product Portfolio
    • 22.4.3.3. Key Financial
    • 22.4.3.4. Sales Footprint
    • 22.4.3.5. SWOT Analysis
    • 22.4.3.6. Strategy Overview
      • 22.4.3.6.1. Marketing Strategies
      • 22.4.3.6.2. Product Strategies
      • 22.4.3.6.3. Channel Strategies
  • 22.4.4. Cook Medical Inc.
    • 22.4.4.1. Overview
    • 22.4.4.2. Product Portfolio
    • 22.4.4.3. Key Financial
    • 22.4.4.4. Sales Footprint
    • 22.4.4.5. SWOT Analysis
    • 22.4.4.6. Strategy Overview
      • 22.4.4.6.1. Marketing Strategies
      • 22.4.4.6.2. Product Strategies
      • 22.4.4.6.3. Channel Strategies
  • 22.4.5. Devicor Medical Products, Inc.
    • 22.4.5.1. Overview
    • 22.4.5.2. Product Portfolio
    • 22.4.5.3. Key Financial
    • 22.4.5.4. Sales Footprint
    • 22.4.5.5. SWOT Analysis
    • 22.4.5.6. Strategy Overview
      • 22.4.5.6.1. Marketing Strategies
      • 22.4.5.6.2. Product Strategies
      • 22.4.5.6.3. Channel Strategies
  • 22.4.6. F. Hoffmann-La Roche Ltd.
    • 22.4.6.1. Overview
    • 22.4.6.2. Product Portfolio
    • 22.4.6.3. Key Financial
    • 22.4.6.4. Sales Footprint
    • 22.4.6.5. SWOT Analysis
    • 22.4.6.6. Strategy Overview
      • 22.4.6.6.1. Marketing Strategies
      • 22.4.6.6.2. Product Strategies
      • 22.4.6.6.3. Channel Strategies
  • 22.4.7. GE Healthcare
    • 22.4.7.1. Overview
    • 22.4.7.2. Product Portfolio
    • 22.4.7.3. Key Financial
    • 22.4.7.4. Sales Footprint
    • 22.4.7.5. SWOT Analysis
    • 22.4.7.6. Strategy Overview
      • 22.4.7.6.1. Marketing Strategies
      • 22.4.7.6.2. Product Strategies
      • 22.4.7.6.3. Channel Strategies
  • 22.4.8. Hologic, Inc.
    • 22.4.8.1. Overview
    • 22.4.8.2. Product Portfolio
    • 22.4.8.3. Key Financial
    • 22.4.8.4. Sales Footprint
    • 22.4.8.5. SWOT Analysis
    • 22.4.8.6. Strategy Overview
      • 22.4.8.6.1. Marketing Strategies
      • 22.4.8.6.2. Product Strategies
      • 22.4.8.6.3. Channel Strategies
  • 22.4.9. Leica Biosystems
    • 22.4.9.1. Overview
    • 22.4.9.2. Product Portfolio
    • 22.4.9.3. Key Financial
    • 22.4.9.4. Sales Footprint
    • 22.4.9.5. SWOT Analysis
    • 22.4.9.6. Strategy Overview
      • 22.4.9.6.1. Marketing Strategies
      • 22.4.9.6.2. Product Strategies
      • 22.4.9.6.3. Channel Strategies
  • 22.4.10. Medax Srl Unipersonale
    • 22.4.10.1. Overview
    • 22.4.10.2. Product Portfolio
    • 22.4.10.3. Key Financial
    • 22.4.10.4. Sales Footprint
    • 22.4.10.5. SWOT Analysis
    • 22.4.10.6. Strategy Overview
      • 22.4.10.6.1. Marketing Strategies
      • 22.4.10.6.2. Product Strategies
      • 22.4.10.6.3. Channel Strategies
  • 22.4.11. Planmed Oy
    • 22.4.11.1. Overview
    • 22.4.11.2. Product Portfolio
    • 22.4.11.3. Key Financial
    • 22.4.11.4. Sales Footprint
    • 22.4.11.5. SWOT Analysis
    • 22.4.11.6. Strategy Overview
      • 22.4.11.6.1. Marketing Strategies
      • 22.4.11.6.2. Product Strategies
      • 22.4.11.6.3. Channel Strategies
  • 22.4.12. Scion Medical Technologies, LLC
    • 22.4.12.1. Overview
    • 22.4.12.2. Product Portfolio
    • 22.4.12.3. Key Financial
    • 22.4.12.4. Sales Footprint
    • 22.4.12.5. SWOT Analysis
    • 22.4.12.6. Strategy Overview
      • 22.4.12.6.1. Marketing Strategies
      • 22.4.12.6.2. Product Strategies
      • 22.4.12.6.3. Channel Strategies
  • 22.4.13. Siemens Healthineer
    • 22.4.13.1. Overview
    • 22.4.13.2. Product Portfolio
    • 22.4.13.3. Key Financial
    • 22.4.13.4. Sales Footprint
    • 22.4.13.5. SWOT Analysis
    • 22.4.13.6. Strategy Overview
      • 22.4.13.6.1. Marketing Strategies
      • 22.4.13.6.2. Product Strategies
      • 22.4.13.6.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료